ArticlePharmaceutics2025

Engineering a Dual-Function Starch-Cellulose Composite for Colon-Targeted Probiotic Delivery and Synergistic Gut Microbiota Regulation in Type 2 Diabetes Therapeutics.

Ruixiang Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.